COVID-19 Research Funding

NIHR funding urgent research into COVID-19 with UKRI

Working with UK Research and Innovation, the NIHR is funding rapid research to support the response to the COVID-19 pandemic. The funded projects will lead to a benefit in UK, potentially international, public health within 12 months.

We have held two funding rounds that have invested £24.6 million into 27 research projects to respond to the coronavirus pandemic:

  • COVID-19 vaccine and therapies research boosted by six new projects in £10.5 million rapid funding round

  • £14.1 million funding announced for new COVID-19 research on treatments, vaccines and epidemiology

We are now holding a rolling funding call for proposals for research into COVID-19, as part of our single, national prioritisation process for COVID-19 research.

The rolling call will close to new applications on 30 June 2020, as the nature of the questions that need to be addressed is changing and funding for longer than 12 months is becoming increasingly necessary.

Get funding for ideas that address COVID-19

Proposals are invited for short-term projects addressing and mitigating the health, social, economic, cultural and environmental impacts of the COVID-19 outbreak

  • Project length: Up to 18 months

  • Closing date: none - apply at any time

  • Funding: 80% of the full economic cost (fEC) for Research Council funding.

  • Award range: There is no specific budget for this call. We are interested in funding research of any scale that can demonstrate it will deliver impact in the project length.